Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison.
Machado FLDS, Cañás M, Doubova SV, Urtasun MA, Marín GH, Osorio-de-Castro CGS, Albuquerque FC, Ribeiro TB, Pont L, Crisóstomo Landeros J, Roldán Saelzer J, Sepúlveda Viveros D, Acosta A, Machado Beltrán MA, Gordillo Alas LI, Orellana Tablas LA, Benko R, Convertino I, Bonaso M, Tuccori M, Kirchmayer U, Contreras Sánchez SE, Rodríguez-Tanta LY, Gutierrez Aures Y, Lin B, Alipour-Haris G, Eworuke E, Lopes LC. Machado FLDS, et al. Among authors: lopes lc. Regul Toxicol Pharmacol. 2023 Oct;144:105485. doi: 10.1016/j.yrtph.2023.105485. Epub 2023 Sep 1. Regul Toxicol Pharmacol. 2023. PMID: 37659711
Biological drugs for the treatment of psoriasis in a public health system.
Lopes LC, Silveira MS, Camargo IA, Barberato-Filho S, Del Fiol Fde S, Osorio-de-Castro CG. Lopes LC, et al. Rev Saude Publica. 2014 Aug;48(4):651-61; discussion 661. doi: 10.1590/s0034-8910.2014048005109. Rev Saude Publica. 2014. PMID: 25210824 Free PMC article.
Data sources for drug utilization research in Latin American countries-A cross-national study: DASDUR-LATAM study.
Lopes LC, Salas M, Osorio-de-Castro CGS, Leal LF, Doubova SV, Cañás M, Dreser A, Acosta A, Baldoni AO, de Cássia Bergamaschi C, Mota DM, Gómez-Galicia DL, Sepúlveda-Viveros D, Delgado EN, da Costa Lima E, Chandia FV, Ferre F, Marin GH, Olmos I, Zimmermann IR, Fulone I, Roldán-Saelzer J, Sánchez-Salgado JC, Castro-Pastrana LI, de Souza LJC, Beltrán MM, Silva MT, Mena MB, de França Fonteles MM, Urtasun MA, Tarapués M, Hernández PG, Medero N, Herrera-Comoglio R, Barberato-Filho S, Galvão TF, Luiza VL, Santa-Ana-Tellez Y, Rodríguez-Tanta Y, Elseviers M. Lopes LC, et al. Pharmacoepidemiol Drug Saf. 2022 Mar;31(3):343-352. doi: 10.1002/pds.5404. Epub 2022 Jan 13. Pharmacoepidemiol Drug Saf. 2022. PMID: 34957616
Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study.
Leal LF, Osorio-de-Castro CGS, de Souza LJC, Ferre F, Mota DM, Ito M, Elseviers M, Lima EDC, Zimmernan IR, Fulone I, Carvalho-Soares MDL, Lopes LC. Leal LF, et al. Among authors: lopes lc. Front Pharmacol. 2022 Jan 14;12:789872. doi: 10.3389/fphar.2021.789872. eCollection 2021. Front Pharmacol. 2022. PMID: 35115935 Free PMC article.
221 results